Risk of diabetes mellitus among users of immune checkpoint inhibitors: A population‐based cohort study

Cancer Medicine（2023）

引用 1|浏览27

暂无评分

摘要

Users of ICI may have a substantial risk of new-onset DM, which may be higher in males but did not differ between PD-1i and PD-L1i.

查看译文

关键词

CTLA-4,PD-1,PD-L1,competing risk,diabetes,immune checkpoint inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要